JPRN-UMIN000003776已完成4 期
Study on quality use of angiotensin II receptor blockers -Comparison between valsartan and olmesartan- - Chronotherapy of ARBs
Division of Clinical Pharmacology, Department of Pharmacology, Jichi Medical University0 个研究点目标入组 150 人开始时间: 2010年6月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 150
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •I. Have an anamnesis to the drug II. Pregnant or potentially pregnant women III. Severe renal impairment (more than twice the standard value of serum creatinine, including the case in hemodialysis) IV. Have been diagnosed with secondary hypertension V. Shift workers and night workers (Have an irregular rhythm of life-style) VI.Judged inappropriate to participate in this study by a doctor
研究者
相似试验
已完成
不适用
Evaluation of the effect of AngiotensinII receptor blocker on coronary artery after Sirolimus-Eluting Stent implantatioJPRN-UMIN000001822Toyohashi Heart Ceter, Cardiovascular Medicine50
尚未招募
不适用
Incidence of COVID-19 disease and the severity of SARS-CoV-2 infection and relationship with angiotensin II type 1 receptor (ATII-1R) concentration in healthcare professionals.ACTRN12621000013864Patrycja Lesnik, MD, PhD80
尚未招募
不适用
The Safety and Efficacy of Angiotensin II Receptor Blockers (ARBs) in Diabetic Patients with Advanced Chronic Kidney DiseaseDiabetic patients with advanced chronic kidney disease (CKD) who have newly received ARBschronic kidney disease, diabetes mellitus, angiotensin II receptor blockers, renin-angiotensin system inhibitorsTCTR20210526006Division of Nephrology, Department of Internal Medicine, Thammasat University Hospital165
已完成
不适用
Effectiveness of angiotensin II receptor blocker for postoperative atrial fibrillation in patients with open heart surgerypatients of open heart surgery with hypertentionJPRN-UMIN000005377Department of Surgery and Clinical Science, Yamaguchi University Graduate School of Medicine120
已完成
4 期
Therapeutic Efficacy of an Angiotensin II Receptor Antagonist in Patients with Nonalcoholic Steathepatitisonalcoholic steatohepatitisJPRN-C000000202Gunma Liver Study Group10